Lurasidone CAS NO.367514-87-2

FOB Price:: USD 1.00-1.00 /Gram Get Latest Price

Min.Order Quantity:: 10 Gram

Purity:: 98% min

Port:: QINGDAO

Payment Terms:: L/C,T/T,MoneyGram

Add to Inquiry Cart

Product Details

Keywords

(3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione
(3aR,4S,7R,7aS)-2-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]Methyl}cyclohexyl]Methyl}hexahydro-1H-4,7-Methanoisoindole-1,3(2H)-dione
Lurasidone (SM13496)

Quick Details

ProName: Lurasidone
CasNo: 367514-87-2
Molecular Formula: C28H36N4O2S
Appearance: White to yellowish powder
Application: Anti-Virals
DeliveryTime: Within 3-7 days after receipt of your ...
PackAge: packaged in foil bags or tins
Port: QINGDAO
ProductionCapacity: 100 Kilogram/Month
Purity: 98% min
Storage: keep in dark and cold place
Transportation: By Sea,by Air,By courier like DHL or F...
LimitNum: 10 Gram
Grade: Pharma Grade
NW: 0

Superiority

main service
1.own made fine chemical products
2.out sourcing and quality controlling service in china
3. com for chemical synthesis
4.lab custom synthesis of api and intermadiates
quality assurance
1. nmr，hplc and coa can be supplied
2. free sample for testing

recommend products
sodium dimethyl 5-sulphonatoisophthalate
cas:3965-55-7

Details

lurasidone hydrochloride

[product name] lurasidone hydrochloride
[cas 367514-87-2]
[type] chemical drug 3 + 3
[preparation & specifications] tablet, 40mg, 80mg / tablet

[indications] is an atypical antipsychotic applicable to the treatment of patients with schizophrenia.
[project]
1. drug survey
four controlled studies of adult schizophrenia six weeks lurasidone hydrochloride lurasidone hydrochloride confirmed the efficacy and safety. in these studies, lurasidone hydrochloride large relative to placebo showed marked improvement in the primary efficacy indicators, including at the end of the study the positive and negative syndrome scale (panss) total score and the brief psychiatric rating scale (panss scale derived from ), a total of five tests confirmed the lurasidone hydrochloride tolerability and safety. the most prominent symptoms include hallucinations, delusion, thinking and behavior disorders, and paranoia. hear the other person can not hear the voice is the most common type of hallucination.
2, market prospects
lurasidone hydrochloride (lurasidone hci) belongs to the class of atypical antipsychotics, was developed by the japanese company sumitomo pharma atypical antipsychotics have a dual role, october 28, 2010 the fda approved the listing for schizophrenia treatment of patients under the trade name latuda, 1 times the recommended daily dose tablet, first-line treatment for patients with schizophrenia.
may 2012 dainippon pharmaceutical pharmaceuticals report, latuda (lurasidone hydrochloride) reached the primary endpoint and key secondary endpoint in both type i bipolar disorder depression in phase iii trials, and plans by the end of the us food and drug administration (fda) to submit lurasidone hydrochloride treatment of bipolar i disorder depression supplemental new drug application (snda).

3. advantages
1) tablet daily, convenient oral administration.
2) effective. for the 5-ht2a receptor and dopamine d2 receptors have high affinity. the positive and negative symptoms of mental patients have a significant effect.
3) studies have reported lurasidone can improve cognitive function.
4) the second indications for the treatment of bipolar disorder are in phase iii clinical. plans to submit a supplemental application end.
4, r & d progress
our company has completed the synthesis of small test, test, production technology, manufacturers are seeking cooperation.